Newsroom | 5700 results

BOSTON--(BUSINESS WIRE)--Zelis, a leading provider of healthcare technology solutions, is certified as a Great Place to Work® in both the United States and India. In the U.S., Zelis earned the recognition for a fourth consecutive year, while Zelis India achieved certification for a third year in a row. This recognition is based entirely on associate feedback and reflects the vibrant culture Zelis associates have built. With more than 3,000 associates in 9 office locations across two countries,...

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a leader in AI-driven revenue cycle management solutions and a business partner to more than half of pharmacies across the United States, today expressed strong support for H.R. 3164, the Main Street Pharmacy Access Act, which was advanced by the full House Ways and Means Committee after mark-up. The legislation has earned broad, bipartisan support, with more than 100 Congressional co-sponsors and the support of major healthcare organizations. XiFin join...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has upgraded the Financial Strength Rating to A (Excellent) from A- (Excellent) and the Long-Term Issuer Credit Rating to “a” (Excellent) from “a-” (Excellent) of Healthcare Providers Insurance Company and its reinsured affiliate, HPIC Risk Retention Group. Both companies are domiciled in Charleston, SC, and are members of Healthcare Providers Insurance Group (HPIC). The outlook of these Credit Ratings (ratings) has been revised to stable from positive. T...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Arrivo Bio will be giving both an oral and poster presentation at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, taking place May 26–29 in Miami, Florida. The presentations will highlight Forvisirvat (SP-624), Arrivo’s first-in-class oral activator of the SIRT6 enzyme, currently in a Phase 2b/3 study for major depressive disorder, with data read out expected later this year. Prior Phase 2 data demonstrated a signal of efficacy...

AUSTIN, Texas--(BUSINESS WIRE)--SureCo, the nation’s leading large-group Individual Coverage Health Reimbursement Arrangement (ICHRA) administrator, today published its 2026 State of ICHRA Report, the most comprehensive longitudinal study of the ICHRA market to date. Drawing on three consecutive years of nationwide survey data from 1,500 HR professionals, employees, and benefits consultants, the report documents 2026 as the year ICHRA crossed from early-adopter experiment to mainstream benefits...

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, today announced the asset acquisition of CaduceusHealth, a nationally recognized revenue cycle management services provider. The acquisition expands Innovaccer's Flow suite to full-stack revenue cycle capabilities, making Flow the first AI-native platform that unifies scheduling, patient engagement, and end-to-end revenue cycle management into a single operating layer for ambulatory care. This marks Innovaccer's f...

LOS ANGELES--(BUSINESS WIRE)--COPE Health Solutions (CHS), a national technology-enabled, platform and services company powering payer and provider performance in risk-based models, today announced the launch of ARCi™, its enterprise suite of agentic AI solutions purpose-built to improve quality and financial performance by automating high-volume workflows, expanding workforce capacity, and driving improved member and patient engagement at scale. Developed by expert clinicians, healthcare opera...

OAKLAND, Calif.--(BUSINESS WIRE)--Migraine Drugs' share of California workers' comp prescriptions is up fourfold since 2018 and their share of the payments has soared from 0.5% to 7.5%...

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., the premier global consulting and actuarial firm, today announced the release of the 2026 Milliman Medical Index (MMI), which measures healthcare costs for Americans covered by a typical employer-sponsored health insurance plan. Healthcare costs for the average person rose 7.9% in 2026 to $8,460—the highest annual increase in more than a decade, excluding pandemic-era fluctuations. Healthcare costs for the MMI’s hypothetical family of four reached $37,8...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Centers for Medicare & Medicaid Services’ (CMS) Molecular Diagnostic Services Program (MolDX) has expanded coverage for the company’s NeXT Personal minimal residual disease (MRD) test. The new coverage determination is for monitoring treatment response to neoadjuvant therapy (NAT) in patients diagnosed with Stage II-III Triple-Negative Breast Canc...